Canada becomes the first country to approve the use of Covifenz

Daily Current Affairs / Canada becomes the first country to approve the use of Covifenz

Change Language English Hindi

Category : International Published on: March 03 2022

Share on facebook

Canada on Thursday approved the use of Covifenz, the world’s first plant-derived Covid-19 vaccine jointly developed by Medicago Inc. and GlaxoSmithKline Plc.
The vaccine has been cleared for people aged 18 to 64 since its safety and effectiveness.
Covifenz is made from plant-based proteins that look like coronavirus and uses Glaxo’s adjuvant that contains DL-alpha-tocopherol, squalene, polysorbate 80, phosphate-buffered saline.
The other ingredients include potassium phosphate monobasic anhydrous, anhydroussodium chloride, sodium phosphate dibasic anhydrous, and water for injection.

Canada becomes the first country to approve the use of Covifenz